Live feed16:05:00·681dPRReleasevia QuantisnowHumacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular TraumaByQuantisnow·Wall Street's wire, on your screen.HUMA· Humacyte Inc.Health Care
